Clinical Trials · NCT07770841

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Name: Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 3Semaglutide

Phase: Phase 3
Recruitment status: Recruiting
Sponsor: Novo Nordisk A/S
Enrollment: 450
Start date: Aug 2026
Locations: 62 sites, 10 countries
Primary endpoint: Relative change in body weight

View Semaglutide compound reference